INDRAPRASTHA MEDICAL CORPORATION
|
|
BOM : 532150     NSE : INDRAMEDCO     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Mar 20,2023 |
Price(EOD): ₹ 78.38
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 718.74 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
INDRAPRASTHA MEDICAL CORPORATION | -2.2% | -5% | 26.5% |
APOLLO HOSPITALS ENTERPRISE | 0.2% | -7.3% | -12% |
MAX HEALTHCARE INSTITUTE | -0.3% | 9% | 31.5% |
FORTIS HEALTHCARE | -0.7% | -3.7% | 3.8% |
DR LAL PATHLABS | -2.5% | -9.9% | -32.4% |
NARAYANA HRUDAYALAYA | 0.3% | 8.9% | 17% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | -1.3% | -4.7% | 1.3% |
ASTER DM HEALTHCARE | 3.3% | 6.5% | 35.3% |
RAINBOW CHILDRENS MEDICARE | 3.4% | -3.3% | NA |
FUNDAMENTAL ANALYSIS OF INDRAPRASTHA MEDICAL CORPORATION
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF INDRAPRASTHA MEDICAL CORPORATION
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
8.82
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 81.51 Cr
[Latest Qtr - Dec2022 - Standalone Results ] 2.21
P/B Calculated based on Book Value of Rs 325.44 Cr
[Latest Year - Mar2022 - Standalone Results ] 0.69
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2022 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-25% -27% -9% |
SHARE PRICE MOMENTUM OF INDRAPRASTHA MEDICAL CORPORATION
INDRAPRASTHA MEDICAL CORPORATION vs SENSEX
DEBT OF INDRAPRASTHA MEDICAL CORPORATION
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0 0 0.01 - |
- - - - |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF INDRAPRASTHA MEDICAL CORPORATION
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF INDRAPRASTHA MEDICAL CORPORATION
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-2.34% -13.21% -12.86% -16.83% |
17.37% 20.89% 32.24% 31.28% |
QtrlyTrend |
0 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
INDRAPRASTHA MEDICAL CORPORATION related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 0.1% | -3.4% | -9.9% |
S&P BSE ALLCAP | -1% | -4.8% | 0.8% |
S&P BSE MIDSMALLCAP | -1.5% | -3.4% | 1.2% |
S&P BSE SMALL CAP | -1.7% | -3.5% | -0.3% |
You may also like the below Video Courses
FAQ about INDRAPRASTHA MEDICAL CORPORATION
Is INDRAPRASTHA MEDICAL CORPORATION good for long term investment?
As on Mar 20,2023, the Fundamentals of INDRAPRASTHA MEDICAL CORPORATION look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of INDRAPRASTHA MEDICAL CORPORATION . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is INDRAPRASTHA MEDICAL CORPORATION UnderValued or OverValued?
As on Mar 20,2023, INDRAPRASTHA MEDICAL CORPORATION is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of INDRAPRASTHA MEDICAL CORPORATION ?
As on Mar 20,2023, the Intrinsic Value of INDRAPRASTHA MEDICAL CORPORATION is Rs. 104.34 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 104.34
Fair Value [Median EV / Sales Model] : Rs. 106.75
Fair Value [Median Price / Sales Model] : Rs. 86.09
Estimated Median Fair Value of INDRAPRASTHA MEDICAL CORPORATION : Rs. 104.34
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is INDRAPRASTHA MEDICAL CORPORATION trading at a Premium or Discount?
As on Mar 20,2023, INDRAPRASTHA MEDICAL CORPORATION is trading at a Discount of -25% based on the estimates of Median Intrinsic Value!